Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Merit Medical Systems, Inc.
MMSI
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $4.1B
$71.09
▲ +2.36%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$59.74 - $96.74
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 25.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Established distribution network with direct sales force, distributors, and OEM partnerships across US and international markets
- Specialized expertise in single-use medical device design and manufacturing for complex interventional procedures
- Diversified product portfolio across multiple high-growth medical specialties reduces customer concentration risk
- Custom procedural solutions capability enables long-term hospital partnerships and switching costs
- Recurring revenue model from consumable products used in routine clinical procedures
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Stable outlook
Aging global population driving increased demand for minimally invasive cardiac and vascular interventions
Value
Fairly valued vs Medical Devices peers
Momentum
Stable
+2.6% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying MMSI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 22, 2026
APR 30, 2026
Reported EPS of $0.94 vs $0.84 consensus (+11.9% surprise). Revenue of $381.9M vs $377.6M expected (+1.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+11.9%
Next: Apr 22, 2026
Revenue trend · last 8Q
—
—
+10%
+10%
+13%
+13%
+11%
+8%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$338.0M
$339.8M
$355.2M
$355.4M
$382.5M
$384.2M
$393.9M
$382.4M
Margins · last 8Q
Gross
—
Operating
—
Profit
10.7%
Wall Street consensus
6 analysts · 83% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
83%
Hold
17%
Sell
0%
Median Price Target
$96.00
▲ +35.0% vs $71.09
Latest: Wells Fargo · May 1, 2026
3 analysts covering